- CRS Publications
- News
News
Authors:
Date:
Business Wire: July 14, 2016 – MONTGOMERY, TX, U.S.A. – AngioSoma, Inc. (OTCQB: SOAN), previously known as First Titan Corp. (the “company,” “we,” and “our”), changed our corporate name and focus to that of a clinical-stage biopharmaceutical company, introducing an exciting new treatment for one of…
Authors:
Date:
Business Wire: June 14, 2016 – WOBURN, MA, U.S.A. – Wolfe Laboratories today announced that Frank Tagliaferri, PhD, has been appointed vice president, pharmaceutical development, effective immediately. Dr. Tagliaferri will lead technical operations for Wolfe’s rapidly growing client base, bringing…
Authors:
Date:
Business Wire: July 13, 2016 – LEXINGTON, MA, U.S.A. – TARIS Biomedical LLC, a company developing powerful and targeted new treatments for millions of patients suffering from difficult-to-treat bladder diseases, announced today the initiation of a phase 1b clinical trial of TAR-200 (GemRIS™) in…
Authors:
Date:
Business Wire: July 12, 2016 – WOBURN, MA, U.S.A. – Aphios Corporation announced today that it has been awarded a subcontract for the nanoformulation of a superhydrophobic anticancer drug administered through the Frederick National Laboratory for Cancer Research in Frederick, Maryland.
Several…
Authors:
Date:
Business Wire: July 6, 2016 – SAN ANTONIO, TX, U.S.A. – Southwest Research Institute (SwRI) and the University of Texas at San Antonio (UTSA) Office of the Vice President for Research announced two new research projects through the Connecting Through Research Partnerships (Connect) Program. The…
Authors:
Date:
Business Wire: July 5, 2016 – PALM BEACH GARDENS, FL, U.S.A. – Transdermal Delivery Solutions Corporation (TDSC), www.TDSC.us, announced today the signing of a product license arrangement with MHC Medical Products, LLC of Cincinnati, Ohio.
“We are pleased to announce the finalization of our…
